Biologics News
-
Japan's EditForce & Mitsubishi ink gene therapy deal for ¥20 B
Biologics | News | 0 Comment | 05 Jul, 2022
Japan-based EditForce has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research,...Read more
-
VerImmune and Fosun Pharma focus on virus-inspired particle based novel immunotherapies in China
Biologics | News | 0 Comment | 23 May, 2022
US-based startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...Read more
-
South Korean firms lay focus on immune cell therapy
Biologics | News | 0 Comment | 29 Apr, 2022
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...Read more
-
Korean startup ImmuneOncia enhances biologics portfolio for cancer patients
Biologics | News | 0 Comment | 28 Dec, 2021
ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology startup in South Korea, has announced that a Memorandu...Read more
-
'Biocon Biologics to work with RSSDI to train ~400 HCPs in India'
Biologics | Opinion | 4 Comment | 01 Dec, 2021
What additional scientific data did you have to submit to the US FDA for obtaining interchangeable biosimilar approval f...Read more
-
China-based BeiGene to open manufacturing site in US for advanced new medicines
Biologics | News | 0 Comment | 24 Nov, 2021
BeiGene, headquartered in China, has purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, N.J.,...Read more
-
Masco Group Acquire Keyplants AB, a Leading Global Provider of Modular Life Science Facilities
Biologics | News | 0 Comment | 09 Nov, 2021
KeyPlants is a leading international industry partner for standardized as well as customized process-integrated modular ...Read more
-
Singapore scientists discover a novel strategy to tame aggressive breast cancer
Biologics | News | 0 Comment | 07 Oct, 2021
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) a...Read more
-
ValenzaBio partners ProBioGen to maximize cell line productivity in Europe
Biologics | News | 0 Comment | 09 Aug, 2021
ProBioGen and ValenzaBio jointly initiate a cell line development project involving the application of ProBioG...Read more
-
Bioreactor sales upsurge with ramped-up COVID-19 vaccine production
Biologics | Opinion | 4 Comment | 25 May, 2021
Bioreactor technology has evolved over time and is still expanding as its requirements in biopharmaceutical and biotechn...Read more
-
BeiGene receives manufacturing approval for biologics facility in China
Biologics | News | 0 Comment | 08 Apr, 2021
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...Read more
-
Abu Dhabi based ADQ invests Rs 555 crore in Biocon Biologics
Biologics | News | 0 Comment | 08 Jan, 2021
Biocon Ltd, an innovation-led global biopharmaceuticals company based in India, announced that the Board of its subsidia...Read more
-
Celltrion to invest $520M for new plant in China
Biologics | News | 0 Comment | 24 Jan, 2020
South Korea's Celltrion Inc. said it will spend 600 billion won (US$520 million) on its new plant in China over the next...Read more
-
Singapore to host 7th Annual Biologics Manufacturing Asia 2020
Biologics | News | 0 Comment | 28 Oct, 2019
The biologics industry in Asia- Pacific is estimated to be the fastest-growing market in the world. For instance, Asia- ...Read more
-
Biocon Biologics expands R&D footprint
Biologics | News | 0 Comment | 24 Sep, 2019
Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&...Read more
-
I-Mab gets IND approval for TJC4 antibody
Biologics | News | 0 Comment | 15 Jul, 2019
I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovat...Read more
-
Potential treatment strategies for human cancer uncovered in bats
Biologics | News | 1 Comment | 02 Jul, 2019
Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in ba...Read more
-
NMPA accepts NDA for biosimilar product candidate of Rituximab
Biologics | News | 0 Comment | 27 Jun, 2019
Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (N...Read more
